Jadenu deferasirox is an ironchelating agent provided as a tablet or granules for oral use. Clarithromycin paediatric suspension msds msdsdigital. Deferasirox is one such agent and the drug has shown significant antitumor effects in a number of in vitro and in vivo studies. If symptoms of poisoning become evident, contact a poisons information centre, or call a doctor at once. Consider repaglinide dose reduction and monitor blood glucose levels. Add new user a password link will be sent to this users email address make admin view only add user. If victims of chemical overexposure are taken for medical attention. Your new online msds binder is a place for you to store the material safety data sheets you need to deploy.
Active pharmaceutical ingredients lists of our established and commercially available pharmaceuticals apis are available as a pdf download here. Vinyltrichlorosilane safety data sheet 06162015 en english us sds id. Buy deferasiroxd4 cas 13425758, a labeled tridentate iron chelator, from santa cruz. Deferasirox is an iron chelator commonly used to treat ironoverload disease. Deferasirox inhibited the proliferation of all gastric cancer cell lines as assessed by mtt assays. We offer publicly available, official documentary standards for pharmaceutical ingredients in the usp. Deferasirox has a survival benefit for sio leukemia murine model in terms of iron chelation and antileukemic therapy3. Usp reference standards are rigorously tested and evaluated by multiple independent commercial, regulatory, and academic laboratories to confirm accuracy and reproducibility. M of deferasirox for 24 or 48 h, and proliferation is determined by an mtt assay2. Since the ic 50 of deferasirox was the lowest below 10. Degarelix acetate is the acetate form of a longacting, synthetic peptide with gonadotrophinreleasing hormone antagonistic properties. Deferasirox is designated chemically as 43,5bis2hydroxyphenyl1 h 1,2,4triazol1ylbenzoic.
Illustration showing the effect of various amounts of mannitol and sds on dissolution. Exjade deferasirox is indicated for the treatment of chronic iron overload due to blood transfusions transfusional hemosiderosis in patients 2 years of age and older. This material safety data sheet complies with the requirements of regulation ec no. Download product insert pdfdownload safety data sheet sds pdf. Deferasirox side effects, dosage, interactions drugs. Safety data sheet created using sdsonline creation tool. The information given is designed only as a guidance for safe. Absorb with liquidbinding material sand, diatomite, acid. The potential of deferasirox as a novel therapeutic.
Safety data sheet according to 29cfr19101200 and ghs rev. Exjade deferasirox tablets for oral suspension 4, 5. The information provided in this safety data sheet is correct to the best of our knowledge, information and belief at the date of its publication. Deferasirox binds to iron and removes it from the blood stream. Sds are documents that provide critical information about hazardous chemicals.
Efficacy and safety of deferasirox in nontransfusion. Exjade increases the exposure of the cyp2c8 substrate repaglinide. Material safety data sheet msds section 2 hazardous ingredientsidentity information section 3 physicalchemical characteristics section 4 fire and explosion hazard data section 5. Accidental release measures contain spill and collect, as appropriate. Sds of deferasirox, safety data sheets, cas 201530418. Study to evaluate treatment compliance, efficacy and. Deferasirox loaded on fumed silica nanoparticles used in. Dailymed jadenu deferasirox tablet, film coated jadenu. Wo2009067557a1 deferasirox pharmaceutical compositions. Deferasirox pharmaceutical compositions download pdf. Monitor plasma concentrations of busulfan when coadministered with deferasirox to allow. Its main use is to reduce chronic iron overload in patients who are receiving longterm blood. As such, the information in it must not be altered, deleted or added to. Deferasirox is used to treat iron overload caused by blood transfusions in adults and children at least 2 years old.
This safety data sheet is issued by the supplier in accordance with whs ghs guidelines. In deferasiroxtreated patients with ntdt syndromes, the most frequently occurring greater than 5% adverse reactions are diarrhea, rash and. Deferasirox also displays both neuroprotective and chemotherapeutic benefit as well. Bioboosttm all natural foliar fertilizer product no.
This is a randomized, openlabel, multicenter, two arm, phase ii study to evaluate treatment compliance and change in serum ferritin of a deferasirox granule formulation and a. The world s hardest floors cali bamboo material safety data sheet 6. Variants manufacturers product codes finished goods code. Accidental release measures accidental release measures. Deferasirox impurity 1 tlc pharmaceutical standards. Identification product identifier product name qualipro imidacloprid 2f turf and ornamental. Safety data sheet according to federal register vol.
765 1396 118 220 128 401 727 1237 878 933 219 1405 1316 540 597 1249 859 1535 1414 7 364 1411 965 654 216 1334 1490 896 976 1218